[Diabetic microangiopathy and nephrosclerosis: genetic, immunologic and biochemical basis of pathomorphologic changes. Therapeutic prospects].
D003925:Diabetic Angiopathies / Q000209:etiology*; D003928:Diabetic Nephropathies / Q000209:etiology*; D004198:Disease Susceptibility; D006680:HLA Antigens / Q000235:genetics; D015235:HLA-B Antigens; D006684:HLA-DR Antigens / Q000235:genetics; D006497:Heparan Sulfate / Q000172:deficiency; D006801:Humans; D007668:Kidney / Q000098:blood supply*; D009400:Nephrosclerosis / Q000209:etiology* / Q000601:surgery
D006680:HLA Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D006497:Heparan Sulfate
Mikroangiopatia cukrzycowa i stwardnienie nerek--podstawy genetyczne, immunologiczne i biochemiczne zmian patomorfologicznych. Perspektywy leczenia.